Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - OTHER CURRENT ASSETS
Other Current Assets URGN - UroGen Pharma Ltd.
11.1 M
LAST VALUE
12.95%
2 YEAR CAGR
64.38%
5 YEAR CAGR
58.49%
10 YEAR CAGR